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Trypanocidal activity of novel alkanediamide-linked bis-
benzamidines and bisbenzamidoximes
T. Huang1,∗, N. Kode2, C. Bacchi3, D. Rattendi3, J.J. Van-
den Eynde2, A. Mayence2, N. Yarlett3, I. Londono3
1 Xavier University of Louisiana, New Orleans, LA, USA
2 Xavier University of Louisiana, College of Pharmacy, New
Orleans, LA, USA
3 Pace University, Haskins Laboratories, New York, NY, USA
Background: Human African trpanosomiasis (HAT) is
caused by the protozoan parasites Trypanosoma brucie gam-
biense (T.b.g) and Trypanosoma brucie rhodesiense (T.b.r)
and is usually fatal when left untreated. It is one of the
most neglected tropical diseases in the world causing an
estimated 50,000 deaths annually. Current drug therapy suf-
fers from high toxicity, undesirable intravenous route of
administration and emergence of parasite resistance. The
present study is to evaluate the trypanocidal activity of a
novel series of alkanediamide-linked bisbenzamidines and
bisbenzamidoximes against several clinical isolates of Try-
panosoma brucie.
Methods: A series of 20 bisbenzamidines and bisbenza-
midoximes were synthesized and tested in vitro against a
drug-sensitive strain of T. b. brucei Lab 110 EATRO and a
drugresistant strain of T. b. r. KETRI 243. The bisamidoximes
were designed to improve oral bioavailability by functioning
as orally-active prodrugs of the most active bisamidines. The
in vivo efﬁcacy of 8 bisbenzamidines and bisbenzamidoximes
were evaluated using mice infected with the drug-sensitive
(T. b. brucei Lab 110 EATRO) or drug-resistant strains of
T.b.r. KETRI 2002 and KETRI 2538.
Results: The tested compounds generally showed sim-
ilar in vitro potencies against both strains of T.b. The
most potent compounds were bisbenzamidines linked with
a hexanediamide, heptanediamide or octanediamide group
(inhibitory concentration for 50% (IC50) = 1-3 nM). Several
of the most potent bisbenzamidine compounds were effec-
tive in curing mice infected with the drug-sensitive or
drug-resistant strains of T. b. rhodesiense. Curative doses
were < 15mg/kg/day for 3 days given by the intraperi-
toneal injection in the mouse model of infections. However,
replacing the terminal basic bisamidines with less basic
bisamidoxime groups resulted in prodrugs that were not
orally effective against T. b. brucei infected mice.
Conclusion: The results suggest that alkanediamide-
linked bisbenzamidines are highly effective against T.
brucei, but further optimization of the prodrug strategy is
needed to improve their oral bioavailability.
doi:10.1016/j.ijid.2010.02.594
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critical role of CD2 as an immunoprophylactic agent to
ombat visceral leishmaniasis
. Sinha1,∗, S. Bimal2, S. Sundaram1
Allahabad University, Allahabad, India
Rajendra Memorial Research Institute for Medical Sci-
nces, Patna, Bihar, India
Background: A major Concern for VL prevention appears
o be the inability of their CD4+ T cells to mount an ade-
uate TH1 response which ensures the possible cure of the
isease. Similarly the effectiveness of SAG in intact animal
s determined by the host cell-mediated immune response.
he present study aims at evaluating the use of CD2 antibody
s an immunotherapeutic agent along with SAG in ensur-
ng treatment of BALB/c mice induced with experimental
isceral leishmaniasis.
Methods: Mice were infected with Leishmania donovani
romastigotes. Another set served as control. After seven
eek of infection, a set of mice from infected group was sub-
ected to SAG treatment and another group was subjected
o SAG treatment along with stimulation with antiCD2 anti-
ody.CD4 cells expressing CD-25 were immunophenotyped
nd cytokines like IL-2, IFN- and TNF- were assessed using
ACS. We also looked into cell cycle pattern, expression of
D25+ cells on T cells, percentage of lymphocytes converted
nto lymphoblasts, percentage of activated T lymphocytes
nd IL-2 production. These parameters were evaluated in T
ells both before and after stimulation of their CD2 antigen.
Results: We recorded a substantial enhancement of pro-
ective cytokines which are essential for combating visceral
eishmaniasis infection.We also observed a signiﬁcant reduc-
ion in parasitic load when drugs are used in combination
ith this immunoprophylactic agent
Conclusion: CD2 proved to be an important immunopro-
hylactic agent which if used in combination with drugs can
rovide a suitable and substantial cure against visceral leish-
aniasis
oi:10.1016/j.ijid.2010.02.595
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atients with suspected visceral leishmaniasis in Istanbul
. Cakan1,∗, S. Saribas2, V. Oz1, E. Polat3, M. Aslan2, B.
ocazeybek3
Istanbul University, Forensic Medicine Institue, Istanbul,
urkey
Istanbul University, Cerrahpasa Faculty of Medicine, Istan-
ul, Turkey
Istanbul University Cerrahpasa Faculty of Medicine,
urkey, Turkey
Background: Visceral Leishmaniasis (VL) is a parasitic
isease caused by Leishmania infantum. It is transmitted
hrough bites of infected sand ﬂies (female Phlebotomus).
e aimed to investigate bone marrow and blood samples
btained from the patients with suspected VL.
Methods: Fifty-nine patients with suspected VL from
stanbul were included in this work. Bone marrow and
lood samples of these patients were tested for possible VL
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nfection using several methods including serological tests,
icroscopy, PCR.
Results: Nineteen (32.2%) patients had positive results
or VL after one or more of the tests performed, while only
patients (11.8%) had positive results with all the tests
ncluding Giemsa stain. Four (6.8%) patients had negative
esults based on all the serological tests performed except
or positive results with Giemsa stain, culture and PCR. The
ther 4 (6.8%) patients had positive results with Formol-
el, ELISA IgG (>1.1 ISR) and IFAT IgG, (>1/256) but negative
esults were obtained with direct microscopic examination,
ulture and PCR. Using PCR Leishmania infantum DNA was
etected in 11(18.6%) of the (Leishmania) cultures origi-
ated from the bonemarrow samples. Plasmodium vivaxwas
ound in 2 (3.4%) patients and leptospira was detected in 1
1.7%) patient. One (1.7%) patient was diagnosed with Pneu-
onia (Streptococcus pneumoniae). Forty (67.8%) patients
ad negative results after direct microscopic examination,
ulture, serological tests and PCR. The kappa coefﬁcients
= 0.80 K = 1.00, K = 0.51, K = 0.55 and K = 0.45 were evalu-
ted for PCR and direct microscopic examination, PCR and
ulture, PCR and ELISA, PCR and IFAT and PCR and Formol-
el, as perfect agreement, perfect agreement, moderate
greement and moderate agreement fair moderate, respec-
ively. The probability values (p) for comparisons of all
he above tests with PCR showed a signiﬁcant correlation
p < 0.000)
Conclusion: In conclusion, we found that no single
ethod alone was sufﬁcient enough to diagnose VL accu-
ately; however, combined with PCR, all these methods can
eveal better and sensitive results ultimately leading to a
orrect diagnosis. We also suggest that PCR has to be applied
ith other laboratory diagnostic tests in order to increase
he sensitivity in diagnosis and decrease the possible defects
n diagnosis.
oi:10.1016/j.ijid.2010.02.596
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mmunological proﬁle of CD18-deﬁcient mice during
chistosoma mansoni infection
.S. Espíndola ∗, F.G. Frantz, L.H. Faccioli
Universidade de São Paulo, Faculdade de Ciências Farma-
êuticas de Ribeirão Preto, Ribeirão Preto, SP, Brazil
Background: Schistosomiasis is recognized as the most
mportant human helminth infection in terms of morbidity
nd mortality harboring around 200 million people world-
ide, beeing cosidered a risk for travelers. A study focusing
he role of integrins, which are involved on cellular migra-
ion, antigen presentation and T cell activation, is necessary
n the knowledge of immunopathology during schistoso-
iasis. The aim of this work is to evaluate the role of
D18 molecule, a 2 integrin, in modulate the immune
esponse and pathology during the development of exper-
mental schistosomiasis.
Methods: C57BL/6 (WT) mice and CD18low mice were
ercutaneously infected with 50 cercariae and the para-
itological evaluation was done 48 days after infection. The
dult worms were recovered from the hepatic portal system
nd the liver by perfusion with citrate saline. Ten and 48 days
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fter infection, the cellular recruitment to the bronchoalve-
lar lavage ﬂuid (BALF), as well the number of inﬂammatory
ells present on the peripheral blood and the cytokines
roduction in the lung homogenates were evaluated. To
etermine the proliferation of T CD3+CD4+ cells and the
ytokines production in vitro, splenocytes were stimulated
ith concanavalin-A.
Results: CD18low mice showed an increased suscepti-
ility to infection with S. mansoni since the worm burden
as 135% higher than in the WT group. Nevertheless, the
ellular recruitment to the BALF was similar between WT
nd CD18low mice, while CD18low mice showed a markedly
nhancement on the accumulation of mononuclear cells
n the peripheral blood, suggesting that less effector cells
ould migrate through blood to the inﬂammatory focus.
oreover, T cells from CD18low mice presented reduced
otential to proliferate in the presence of Con-A than cells
rom infected WT mice. Ten days after infection the mea-
urement of TNF-, IL-12, IL-5, IL-10 and IL-4 in the lung
omogenates was always lower in CD18low mice. Although,
8 days after infection, only IL-5 and IL-12 in CD18low mice
howed slightly inferior levels. After in vitro stimulation of
plenocytes with Con-A, just IL-5 production from CD18low
ice was lower than WT.
D18 low mice are more susceptible to infection with S.
ansoni than WT mice. Worm burden was obtained by
erfusion of the hepatic portal system with citrate saline.
* p <0.01
Conclusion: The deﬁciency of CD18 molecule causes an
ncontrolled parasite burden and changes of immune pat-
erns, magnifying the severity of disease.
oi:10.1016/j.ijid.2010.02.597
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ontrol of Chagas disease patients whith chronic form of
ts treatment after Benznidazole treatment
.T. Fraile Farin˜as1,∗, C. Parada Barba2, J.L. Ramos Marti 3,
. Chanza Avino3, M. Garcia Rodriguez3, C. Gimeno
ardona3
Hospital General Universitario de Valencia, Valencia, Spain
Centro de transfusion de la CV, Valencia, Spain
CHGUV, Valencia, SpainBackground: Chagas disease is caused by the parasite
rypanosoma cruzi (TC). It’s estimated that around sixteen
illion people are infected in Latin America and represents
serious blood safety problem due to increasing immigra-
ion from these countries. Following the acute phase of the
